Lay Summary
Special Interest Group for Immune-Mediated Liver Disease
PSC research priorities presented at the BASL Immune-Mediated Liver Disease Special Interest Group.
Read MoreCancer Prevention Survey Results
Survey results published: reducing the risk of cancer is important to people affected by PSC and they are interested in helping reduce the risks of PSC-related cancers.
Read MoreVancomycin: a promising option for the treatment of PSC?
Dr Roger Chapman takes a look at vancomycin and its potential use in PSC.
Read MorePSC Guidelines
The new BSGUK-PSC Guidelines for the diagnosis and management of PSC have been published.
Read MorePSC research is a top priority in the UK liver community
Your survey responses have been acted upon and heard.
Read MorePSC Support works with researchers to improve PSC diagnosis
We are working with researchers to remove the uncertainty around diagnosing PSC.
Read MoreUK-PSC Risk Scores for PSC
A new 2 year and 10 year UK-PSC risk score tool for PSC.
Read MoreResearch of medicine for PSC
PSC Support represents patients at EMA meeting on development of medicines for PSC
Read MorePSC and the role of the clinical nurse specialist
Co-authored by PSC Support, an article about the role of inflammatory bowel disease (IBD) nurses was published.
Read MoreImpact of PSC on mental health and wellbeing
We’re working with psychologists to improve wellbeing for people affected by PSC.
Read More